Forskning ved Københavns Universitet - Københavns Universitet

Forside

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Peter S Sever
  • Björn Dahlöf
  • Neil R Poulter
  • Hans Wedel
  • Gareth Beevers
  • Mark Caulfield
  • Rory Collins
  • Sverre E Kjeldsen
  • Arni Kristinsson
  • Gordon T McInnes
  • Jesper Mehlsen
  • Markku Nieminen
  • Eoin O'Brien
  • Jan Ostergren
  • ASCOT Investigators
The lowering of cholesterol concentrations in individuals at high risk of cardiovascular disease improves outcome. No study, however, has assessed benefits of cholesterol lowering in the primary prevention of coronary heart disease (CHD) in hypertensive patients who are not conventionally deemed dyslipidaemic.
OriginalsprogEngelsk
TidsskriftLancet
Vol/bind361
Udgave nummer9364
Sider (fra-til)1149-58
Antal sider10
ISSN0140-6736
DOI
StatusUdgivet - 5 apr. 2003

ID: 34079207